Immunotherapy delays recurrence for stage III and IV ovarian cancers

28 marzo 2015

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the cancer’s return.